Post by
wilander on Sep 17, 2020 10:12am
This stock could be, much higher
I was lucky to be introduced to this stock in the low $2's just before the big quick run. I questioned whether people would pay 12K for something that just tells you a virus pathogen is in the air and nothing more, but knew the hype would lead to at least a good uptick. It certainly has.
The next step is monetizing the hype.
When I heard late last week the CEO say in an interview they were getting tons of calls for 5-10 units but weren't even considering them, only looking for the "big commercial orders", I sold my position and took the profit.
When a company with virtually NO REVENUE, turns down opportunity to make orders worth $60-120,000 k each and instead only wants the home runs, I pay attention. That doesn;t impress me, it worries me. I've invested in those types before and it rarely ends well.
i am not downplaying the stock, but until I see sales, it is time to step back and wait. Had they been lining up the small orders and announcing all the deals -- showing sales! -- this stock would be flying by now.
Instead its all just an idea.
We have the good news re the product phase but now we need the "show me the money" phase. Until that happens I will sit on the sidelines, waiting to get back in, even if it costs more to do so.
It seems I am not alone.
Comment by
JohnFriesen on Dec 17, 2020 2:07pm
This post has been removed in accordance with Community Policy
Comment by
JohnFriesen on Dec 17, 2020 4:23pm
This post has been removed in accordance with Community Policy